Acceso abierto

Ethical issues in clinical trials in children

European Pharmaceutical Journal's Cover Image
European Pharmaceutical Journal
Clinical Pharmacy in the Slovak Republic, dedicated to the associated professor Lívia Magulová, PhD.

Cite

Based on the authors' presentation given at the 20th Symposium of Clinical Pharmacy in honour of late Assoc. Prof. PharmDr. Lívia Magulová, PhD., Nitra, Slovakia, April 28 - 29, 2011.Search in Google Scholar

Regulation (EC) No 1901/2006 of the European Parliament and the Council, as amended, on medicinal products for paediatric use (‘Paediatric Regulation’). Available at: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:378:0001:0019:EN:PDFSearch in Google Scholar

ICH E11 Note for Guidance on the Clinical Investigation of Medicinal Products in the Paediatric Population (CPMP/ICH/2711/99). Available at: http://www.emea.europa.eu/pdfs/human/ich/271199EN.pdfSearch in Google Scholar

ALRAVILLA, A. - MANFREDI, C. - BAIARDI, P. et al.: Impact of the new European paediatric regulatory framework on ethics committees: overview and perspectives. Acta Paediatr, 2012, 101, No. 1, p. e27-32. (Epub 2011 Jul 23).10.1111/j.1651-2227.2011.02401.x21732978Search in Google Scholar

ICH E11, p. 5 - 6.Search in Google Scholar

ICH E11, p. 5 - 6.Search in Google Scholar

ICH E11, p. 6 - 7.Search in Google Scholar

ICH E11, p. 11 - 13.Search in Google Scholar

Ethical Considerations for Clinical Trials on Medicinal Products Conducted with Paediatric Population. Recommendations of the ad hoc group for the development of implementing guidelines for Directive 2001/20/EC relating to good clinical practice in the conduct of clinical trials on medicinal products for human use. European Commission, 2008, 34 pgs. (further on "EC Recommendations 2008") Available at: http://ec.europa.eu/health/files/eudralex/vol-10/ethical_considerations_en.pdfSearch in Google Scholar

Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use.Search in Google Scholar

EC Recommendations 2008, p. 13.Search in Google Scholar

EC Recommendations 2008, p. 13 - 14.Search in Google Scholar

Committee for Medicinal Products for Human Use (CHMP): Guideline on Conduct of Pharmacovigilance for Medicines Used by the Paediatric Population, EMEA, London, 25 January 2007. Doc. Ref. EMEA/CHMP/PhVWP/235910/2005- rev.1, p. 3 - 4. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003764.pdfSearch in Google Scholar

We refer in this text to the provisions contained in the law No. 326/2011 Coll., which since December 2011 has superseded the original law No. 140/1998 Coll. on medicinal drugs and medical devices. The later version of the medicinal drugs and devices law was valid at the time of delivery of the original authors' presentation (see ref. 1). The text of the law available in Slovak language at: http://www.zbierka.skSearch in Google Scholar

eISSN:
1338-6786
ISSN:
0301-2298
Idioma:
Inglés
Calendario de la edición:
2 veces al año
Temas de la revista:
Pharmacy, other